该中试基地投资3.6亿元，依托的佛山（三水）新材料产业园是佛北战新产业园核心区、佛山十大创新 引领型特色产业园区，坐拥大湾区万亩连片产业空间。值得一提的是，佛山市化工新材料中试基地跳出 传统中试平台运营思维，首创"国资筑基+民企唱戏"的市场化路径，联合行业龙头组建专业团队，整合 技术经验与产业资源推行"中试熟化+产业孵化"一体化运营。 该中试基地针对三水通信天线产业集群优势，布局抛光液、光刻胶等电子化学品中试，填补电子信息产 业上游材料配套空白；紧跟新能源汽车产业热潮，主攻新能源电池配套材料、汽车轻量化材料；瞄准佛 山千亿级生物医药健康产业，研发高端原料药、医药中间体，助力上游原料创新突破；贴合纺织、家具 等传统产业提质需求，打造新型有机硅、环保印染助剂等精细化工产品中试线；前瞻布局未来材料领 域，攻关特种工程塑料、可降解材料等特种功能材料。 日前，佛山市科学技术局发布通知称，确定三水区产发新材料科技有限公司承担佛山市中试基地建设任 务，拟对佛山（三水）新材料产业园中试基地项目认定授牌为"佛山市化工新材料中试基地"。该中试基 地既是佛山首个获认定的中试平台，也是广东省首个公共服务型化工新材料中试基地。 今年6 ...

Core Insights - Shandong Shanghe County focuses on industrial chain extension, supplementation, and strengthening, actively attracting and nurturing "chain leader" enterprises while promoting the integration of small and medium-sized enterprises into the industrial chain [1] Industry Summaries Biopharmaceutical and Chemical Industry - The biopharmaceutical and chemical industry in Shanghe County has seen significant growth, with 47 large-scale enterprises gathered, forming a collaborative development pattern centered on key pharmaceutical intermediates, high-end raw materials, and drug formulations, aiming for a target of 10 billion [1] Equipment Manufacturing Industry - The equipment manufacturing industry has achieved multiple breakthroughs, with 42 large-scale enterprises introduced, including Guangri Co., Ltd. and the Jinan Digital Industry Park, leading to the development of industries such as laser manufacturing and elevator manufacturing from inception to growth [1] Nutritional Food Industry - The nutritional food industry is taking shape, led by major enterprises like Sibote Biotechnology and Jinsah River Noodle Industry, establishing the Qilu Health Food Industrial Park and enhancing cold chain storage logistics, thereby accelerating the transformation of agricultural product resource advantages into industrial development advantages [1]

Core Viewpoint - The news highlights the strategic development of Jinan's industrial sector, particularly focusing on the "Industrial Strong City" initiative and the role of Shanghe County in enhancing industrial clusters and promoting a "chain-based" development model [1][3]. Group 1: Industrial Strategy and Development - Jinan's "Industrial Strong City" strategy aims for a significant upgrade in industrial capabilities by 2025, transitioning from "cluster development" to "chain-based breakthroughs" [1]. - Shanghe County is aligning its industrial development with Jinan's strategic goals, focusing on building a "chain-based" ecosystem that includes leading enterprises and small to medium-sized businesses [2][3]. Group 2: Key Industries and Clusters - The biopharmaceutical and chemical industries in Shanghe are developing a collaborative ecosystem, focusing on key pharmaceutical intermediates and high-end raw materials [2]. - Shanghe is establishing itself as a center for pharmaceuticals and high-end fine chemicals, contributing to Jinan's overall industrial strategy [3]. Group 3: Infrastructure and Service Innovations - Shanghe has introduced an innovative "park within a park" model to facilitate industrial clustering, providing specialized facilities tailored to different industry needs [4]. - The economic development zone in Shanghe is enhancing its infrastructure, including expanding steam supply capacity and wastewater treatment capabilities [4][6]. Group 4: New Production Capacity and Technological Advancements - Companies in Shanghe are focusing on digital transformation and smart manufacturing, with examples like Guangdian Elevator aiming to establish a digital factory [8]. - The region has nurtured specialized small and medium enterprises, contributing to the overall goal of transitioning from traditional manufacturing to intelligent manufacturing [9]. Group 5: Future Outlook and Goals - The year 2025 is pivotal for Jinan's industrial strategy, coinciding with the conclusion of the "Made in China 2025" initiative and the launch of new industrialization plans [9]. - Shanghe is committed to high-quality industrial development, aiming to contribute significantly to Jinan's industrial strength through innovation and strategic growth [9].

Core Insights - The event focused on the "Industrial Strong City Development Strategy" in Jinan, highlighting the efforts of Shanghe County in enhancing its industrial chain and attracting key enterprises [1] Industry Development - Shanghe County has concentrated on extending, supplementing, and strengthening its industrial chains, successfully attracting and nurturing "chain master" enterprises while facilitating the integration of small and medium-sized enterprises into these chains [1] - The biopharmaceutical and chemical industry has seen significant growth, with 47 large-scale enterprises established, focusing on key pharmaceutical intermediates, high-end raw materials, and drug formulations, aiming for a target of 10 billion [1] - The equipment manufacturing sector has achieved multiple breakthroughs, with 42 large-scale enterprises including Guangri Co., Ltd. and the Jinan Digital Industry Park, leading to the development of industries such as laser manufacturing and elevator manufacturing [1] - The nutritional food industry is beginning to take shape, led by major enterprises like Sibote Bio and Jinsha River Noodle Industry, with the establishment of the Qilu Health Food Industrial Park and improvements in cold chain logistics [1]

Core Viewpoint - The Jiangsu Wuxi Biopharmaceutical Industry Special Fund aims to promote the development of strategic emerging industries in Jiangsu Province, with a total scale of 4 billion yuan [1]. Group 1: Fund Structure and Investment Strategy - The fund is established in collaboration with Wuxi City to support the integration and development of strategic emerging industry clusters [1]. - Investment methods include setting up sub-funds or direct project investments, with direct investments generally not exceeding 30% of the actual investment amount of the special fund [1]. - The special fund's contribution to sub-funds will not exceed 30% of the sub-fund's total size, and investments in individual direct projects will not exceed 20% of the total paid-in capital of the special fund [1]. Group 2: Investment Focus Areas - The fund primarily invests in pharmaceuticals (including innovative drugs, high-end raw materials, traditional Chinese medicine, cell gene therapy, synthetic biology, etc.), medical devices (including in vitro diagnostic reagents and supporting instruments), and supportive medical industries (including research instruments, synthetic biology, CXO, new medical infrastructure, MAH platform companies, etc.) [2]. - Additional focus areas include consumer healthcare and improving national health quality (including health management, medical aesthetics, special medical foods, and functional foods), as well as AI in pharmaceuticals [2].